Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins

Molecular Biology of the Cell

Volumn 11, Issue 6, 2000, Pages 1933-1946

  VanSlyke, Judy K ^a   Deschenes, Suzanne M ^a   Musil, Linda S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; DETERGENT; GAP JUNCTION PROTEIN; PROTEASOME INHIBITOR;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GAP JUNCTION; HEREDITARY MOTOR SENSORY NEUROPATHY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LYSOSOME; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; RAT;

EID: 0034047183     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.6.1933     Document Type: Article

References (78)

1. Anzini, P., Neuberg, D.H., Schachner, M., Nelles, E., Willecke, K., Zielasek, J., Toyka, K.V., Suter, U., and Martini, R. (1997). Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17, 4545-4551.
2. Aridor, M., and Balch, W.E. (1999). Integration of endoplasmic reticulum signaling in health and disease. Nat. Med. 5, 745-751.
3. Balice-Gordon, R.J., Bone, L.J., and Scherer, S.S. (1998). Functional gap junctions in the schwann cell myelin sheath. J. Cell Biol. 142, 1095-1104.
4. Beardslee, M.A., Laing, J.G., Beyer, E.C., and Saffitz, J.E. (1998). Rapid turnover of connexin43 in the adult rat heart. Circ. Res. 83, 629-635.
5. Bergoffen, J., Scherer, S.S., Wang, S., Scott, M.O., Bone, L.J., Paul, D.L., Chen, K., Lensch, M.W., Chance, P.F., and Fischbeck, K.H. (1993). Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039-2042.
6. Bone, L.J., Deschenes, S.M., Balice-Gordon, R.J., Fischbeck, K.H., and Scherer, S.S. (1997). Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol. Dis. 4, 221-230.
7. Bonifacino, J.S., and Weissman, A.M. (1998). Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Dev. Biol. 14, 19-57.
8. Brobby, G.W., Muller-Myhsok, B., and Horstmann, R.D. (1998). Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa (letter). N. Engl. J. Med. 338, 548-550.
9. Brodsky, J.L., and McCracken, A.A. (1997). ER-associated and proteasome-mediated protein degradation: how two topologically restricted events came together. Trends Cell Biol. 7, 151-156.
10. Bruzzone, R., White, T.W., Scherer, S.S., Fischbeck, K.H., and Paul, D.L. (1994). Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 73, 1253-1260.
11. Carlson, J.A., Rogers, B.B., Sifers, R.N., Finegold, M.J., Clift, S.M., DeMayo, F.J., Bullock, D.W., and Woo, S.L. (1989). Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J. Clin. Invest. 83, 1183-1190.
12. Cascio, M., Kumar, N.M., Safarik, R., and Gilula, N.B. (1995). Physical characterization of gap junction membrane connexons (hemichannels) isolated from rat liver. J. Biol. Chem. 270, 18643-18648.
13. Castro, C., Gomez-Hernandez, J.M., Silander, K., and Barrio, L.C. (1999). Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. 19, 3752-3760.
14. Cheng, S.H., Fang, S.L., Zabner, J., Marshall, J., Piraino, S., Schiavi, S.C., Jefferson, D.M., Welsh, M.J., and Smith, A.E. (1995). Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. Am. J. Physiol. 268, L615-L624.
15. Cole, N.B., Sciaky, N., Marotta, A., Song, J., and Lippincott-Schwartz, J. (1996). Golgi dispersal during microtubule disruption: regeneration of Golgi stacks at peripheral endoplasmic reticulum exit sites. Mol. Biol. Cell 7, 631-650.
16. Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E., and Welsh, M.J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
17. Deschenes, S.M., Walcott, J.L., Wexler, T.L., Scherer, S.S., and Fischbeck, K.H. (1997). Altered trafficking of mutant connexin32. J. Neurosci. 17, 9077-9084.
18. D'Urso, D., Prior, R., Greiner-Petter, R., Gabreels-Festen, A.A., and Muller, H.W. (1998). Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 18, 731-740.
19. Fallon, R.F., and Goodenough, D.A. (1981). Five-hour half-life of mouse liver gap-junction protein. J. Cell Biol. 90, 521-526.
20. Goodenough, D.A., Goliger, J.A., and Paul, D.L. (1996). Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65, 475-502.
21. Goodenough, D.A., Paul, D.L., and Jesaitis, L. (1988). Topological distribution of two connexin32 antigenic sites in intact and split rodent hepatocyte gap junctions. J. Cell Biol. 107, 1817-1824.
22. Gow, A., and Lazzarini, R.A. (1996). A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat. Genet. 13, 422-428.
23. Gow, A., Southwood, C.M., and Lazzarini, R.A. (1998). Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J. Cell Biol. 140, 925-934.
24. Graham, K.S., Le, A., and Sifers, R.N. (1990). Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP. J. Biol. Chem. 265, 20463-20468.
25. Greenfield, J.P., Tsai, J., Gouras, G.K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S.S., Greengard, P., and Xu, H. (1999). Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. USA 96, 742-747.
26. Hammond, C., and Helenius, A. (1995). Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7, 523-529.
27. Hertzberg, E.L. (1984). A detergent-independent procedure for the isolation of gap junctions from rat liver. J. Biol. Chem. 259, 9936-9943.
28. Hsu, V.W., Yuan, L.C., Nuchtern, J.G., Lippincott-Schwartz, J., Hammerling, G.J., and Klausner, R.D. (1991). A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 352, 441-444.
29. Hurtley, S.M., and Helenius, A. (1989). Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5, 277-307.
30. Ionasescu, V., Ionasescu, R., and Searby, C. (1996). Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am. J. Med. Genet. 63, 486-491.
31. Jackson, M.R., Nilsson, T., and Peterson, P.A. (1993). Retrieval of transmembrane proteins to the endoplasmic reticulum. J. Cell Biol. 222, 317-333.
32. Jensen, T.J., Loo, M.A., Pind, S., Williams, D.B., Goldberg, A.L., and Riordan, J.R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
33. Kamsteeg, E.J., Wormhoudt, T.A., Rijss, J.P., van Os, C.H., and Deen, P.M. (1999). An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J. 18, 2394-2400.
34. Kelsell, D.P., Dunlop, J., Stevens, H.P., Lench, N.J., Liang, J.N., Parry, G., Mueller, R.F., and Leigh, I.M. (1997). Connexin 26 mutations in hereditary non-syndromic sensorineural deafness Nature 387, 80-83.
35. Kim, P.S., and Arvan, P. (1998). Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr. Rev. 19, 173-202.
36. Klausner, R.D., Donaldson, J.G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 226, 1071-1080.
37. Kumar, N.M., Friend, D.S., and Gilula, N.B. (1995). Synthesis and assembly of human beta 1 gap junctions in BHK cells by DNA transfection with the human beta 1 cDNA. J. Cell Sci. 108, 3725-3734.
38. Laing, J.G., and Beyer, E.C. (1995). The gap junction protein connexin43 is degraded via the ubiquitin proteasome pathway. J. Biol. Chem. 270, 26399-26403.
39. Laing, J.G., Tadros, P.N., Westphale, E.M., and Beyer, E.C. (1997). Degradation of connexin43 gap junctions involves both the proteasome and the lysosome. Exp. Cell Res. 236, 482-492.
40. Larsen, W.J., and Tung, H.N. (1978). Origin and fate of cytoplasmic gap junction vesicles in rabbit granulosa cells. Tissue Cell 10, 585-598.
41. Le, A.C., and Musil, L.S. (1998). Normal differentiation of cultured lens cells after inhibition of gap junction-mediated intercellular communication. Dev. Biol. 204, 80-96.
42. Lee, D.H., and Goldberg, A.L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403.
43. Mackay, D., Ionides, A., Kibar, Z., Rouleau, G., Berry, V., Moore, A., Shiels, A., and Bhattacharya, S. (1999). Connexin46 mutations in autosomal dominant congenital cataract. Am. J. Hum. Genet. 64, 1357-1364.
44. Maimone, M.M., and Merlie, J.P. (1993). Interaction of the 43 kd postsynaptic protein with all subunits of the muscle nicotinic acetykholine receptor. Neuron 11, 53-66.
45. Matlin, K.S., and Simons, K. (1983). Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation. Cell 34, 233-243.
46. Mayerhofer, A., Amador, A.G., Beamer, W.G., and Bartke, A. (1988). Ultrastructural aspects of the goiter in cog/cog mice. J. Hered. 79, 200-203.
47. Mege, R.M., Matsuzaki, F., Gallin, W.J., Goldberg, J.I., Cunningham, B.A., and Edelman, G.M. (1988). Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules. Proc. Natl. Acad. Sci. USA 85, 7274-7278.
48. Mellman, I., Fuchs, R., and Helenius, A. (1986). Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55, 663-700.
49. Mulders, S.M., et al. (1998). An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J. Clin Invest. 102, 57-66.
50. Murakami, T., Garcia, C.A., Reiter, L.T., and Lupski, J.R. (1996). Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine 75, 233-250.
51. Musil, L.S. (1994). Structure and assembly of gap junctions. In: Molecular Mechanisms of Epithelial Cell Junctions: From Development to Disease, ed. S. Citi, Austin, TX: R.G. Landes, 173-194.
52. Musil, L.S., Cunningham, B.A., Edelman, G.M., and Goodenough, D.A. (1990). Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J. Cell Biol. 111, 2077-2088.
53. Musil, L.S., and Goodenough, D.A. (1991). Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J. Cell Biol. 225, 1357-1374.
54. Musil, L.S., and Goodenough, D.A. (1993). Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74, 1065-1077.
55. Oh, S., Ri, Y., Bennett, M.V., Trexler, E.B., Verselis, V.K., and Bargiello, T.A. (1997). Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19, 927-938.
56. Omori, Y., Mesnil, M., and Yamasaki, H. (1996). Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol. Biol. Cell 7, 907-916.
57. Plemper, R.K., and Wolf, D.H. (1999). Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 24, 266-270.
58. Ren, P., de Feijter, A.W., Paul, D.L., and Ruch, R.J. (1994). Enhancement of liver cell gap junction protein expression by glucocorticoids. Carcinogenesis 15, 1807-1813.
59. Richard, G., Smith, L.E., Bailey, R.A., Itin, P., Hohl, D., Epstein, E.H., Jr., DiGiovanna, J.J., Compton, J.G., and Bale, S.J. (1998). Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat. Genet. 20, 366-369.
60. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molexules. Cell 78, 761-771.
61. Sadeghi, H.M., Innamorati, G., and Birnbaumer, M. (1997). An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol. Endocrinol. 11, 706-713.
62. Scherer, S.S., Bone, L.J., Deschenes, S.M., Abel, A., Balice-Gordon, R.J., and Fischbeck, K.H. (1999). The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found. Symp. 219, 175-185.
63. Scherer, S.S., Deschenes, S.M., Xu, Y.T., Grinspan, J.B., Fischbeck, K.H., and Paul, D.L. (1995). Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 15, 8281-8294.
64. Scherer, S.S., Xu, Y.T., Nelles, E., Fischbeck, K., Willecke, K., and Bone, L.J. (1998). Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24, 8-20.
65. Seglen, P.O. (1983). Inhibitors of lysosomal function. Methods Enzymol. 96, 737-764.
66. Shiels, A., Mackay, D., Ionides, A., Berry, V., Moore, A., and Bhattacharya, S. (1998). A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am. J. Hum. Genet. 62, 526-532.
67. Skovronsky, D.M., Doms, R.W., and Lee, V.M. (1998). Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141, 1031-1039.
68. Stevens, T.H., and Forgac, M. (1997). Structure, function and regulation of the vacuolar (H+)-ATPase. Annu. Rev. Cell Dev. Biol. 13, 779-808.
69. Tamarappoo, B.K., and Verkman, A.S. (1998). Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. 101, 2257-2267.
70. VanSlyke, J.K., and Musil, L.S. (2000). Analysis of connexin intracellular transport and assembly. Methods 20, 156-164.
71. Wahlberg, J.M., Geffen, I., Reymond, F., Simmen, T., and Spiess, M. (1995). trans-Golgi retention of a plasma membrane protein: mutations in the cytoplasmic domain of the asialoglycoprotein receptor subunit H1 result in trans-Golgi retention. J. Cell Biol. 130, 285-297.
72. Ward, C.L., Omura, S., and Kopito, R.R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.
73. Xia, J.H., et al. (1998). Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat. Genet. 20, 370-373.
74. Yang, B., Ma, T., Xu, Z., and Verkman, A.S. (1999). cDNA and genomic cloning of mouse aquaporin-2: functional analysis of an orthologous mutant causing nephrogenic diabetes insipidus. Genomics 57, 79-83.
75. Yoshimura, T., Satake, M., Ohnishi, A., Tsutsumi, Y., and Fujikura, Y. (1998). Mutations of connexin32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression. J. Neurosci. Res. 51, 154-161.
76. Zhang, F., Kartner, N., and Lukacs, G.L. (1998). Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180-183.
77. Zhou, L., Kasperek, E.M., and Nicholson, B.J. (1999). Dissection of the molecular basis of pp60(v-src) induced gating of connexin 43 gap junction channels. J. Cell Biol. 244, 1033-1045.
78. Zhou, X.W., Pfahnl, A., Werner, R., Hudder, A., Llanes, A., Luebke, A., and Dahl, G. (1997). Identification of a pore lining segment in gap junction hemichannels. Biophys. J. 72, 1946-1953.